<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>Journal of Food and Nutrition Research</journalTitle>
<eissn>2333-1240</eissn>
<publicationDate>2025  #These authors contributed equally to this study and should be considered first authors-07-14</publicationDate>
<volume>13</volume>
<issue>7</issue>
<startPage>232</startPage>
<endPage>239</endPage>
<doi>10.12691/jfnr-13-7-1</doi>
<publisherRecordId>JFNR20251371</publisherRecordId>
<documentType>article</documentType>
<title language="eng">The Mixture of Centella Asiatica Extract and Portulaca Oleracea Extract Promotes Longitudinal Bone Growth in Adolescent Male Sprague-Dawley Rats</title>
<authors>
<author>
<name>Hyun Sook Lee</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Jae In Jung</name>
<affiliationId>2</affiliationId>
</author>
<author>
<name>Seungtae Lim</name>
<affiliationId>3</affiliationId>
</author>
<author>
<name>YoungSun Jang</name>
<affiliationId>4</affiliationId>
</author>
<author>
<name>Eun Ji Kim</name>
<email>myej44@naver.com</email>
<affiliationId>4</affiliationId>
<affiliationId>4</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Department of Food & Nutrition, Dongseo University, Busan, Korea</affiliationName>
<affiliationName affiliationId="2">Industry Coupled Cooperation Center for Bio Healthcare Materials, Hallym University, Chuncheon, Korea</affiliationName>
<affiliationName affiliationId="3">Research Institute, SRE Service Co., Ltd., Chuncheon, Korea</affiliationName>
<affiliationName affiliationId="4">Department of Pharmacy, College of Pharmacy, Kangwon National University, Chuncheon, Korea</affiliationName>

</affiliationsList>
<abstract language="eng">FSG-CA is a mixture of Centella asiatica extract and Portulaca oleracea extract. In previous in vitro studies, FSG-CA was shown to enhance osteoblastic activity. In this study, we investigated the effect of FSG-CA on longitudinal bone growth in vivo. Male adolescent SD rats were divided into four groups and administered FSG-CA (50 or 100 mg/kg BW/day), recombinant human growth hormone (rhGH, positive control), or vehicle (control) for 5 weeks. Longitudinal bone growth rate was measured using tetracycline labeling. Growth plate (GP) height was measured using hematoxylin and eosin staining. Serum GH, insulin-like growth factor (IGF)-1, and IGF-binding protein (IGFBP)-3 concentrations were measured by enzyme-linked immunosorbent assay. In the liver, mRNA expression of IGF-1 and IGFBP-3 was analyzed by RT-PCR. IGF-1 and bone morphogenetic protein (BMP)-2 in the tibial GP were analyzed by immunofluorescence staining. Oral administration of FSG-CA significantly increased endochondral bone formation and proliferation and tibial GP height. FSG-CA increased IGF-1 and IGFBP-3 mRNA expression in the liver and increased IGF-1 concentration in serum. FSG-CA also upregulated IGF-1 and BMP-2 expression in the tibial GP. These results suggest that FSG-CA may help increase longitudinal bone growth during puberty by utilizing the GH - IGF-1 pathway.</abstract>
<fullTextUrl format="pdf">https://pubs.sciepub.com/jfnr/13/7/1/jfnr-13-7-1.pdf</fullTextUrl>
<keywords language="eng"><keyword>Centella asiatica</keyword>
<keyword>Portulaca oleracea</keyword>
<keyword>longitudinal bone growth</keyword>
<keyword>growth plate</keyword>
<keyword>IGF-1</keyword>
</keywords>
</record>
</records>
